市場調查報告書
商品編碼
1403493
居家照護氧氣濃縮機市場至2030年的預測:按產品類型、行銷類型、技術、最終用戶和地區的全球分析Homecare Oxygen Concentrators Market Forecasts to 2030 - Global Analysis By Product, Marketing Type, Technology, End User and By Geography |
根據 Stratistics MRC 的資料,2023年全球居家照護氧氣濃縮機市場規模為 18 億美元,預計在預測期內將以 8%的年複合成長率成長,到2030年達到 31 億美元。
居家照護氧氣濃縮機市場是指提供攜帶式和固定式設備的行業,目的是為患有呼吸系統疾病的人在舒適的家中提供濃縮氧氣。行業領導者提供各種具有不同功能和流量的產品,以滿足不同類型患者的需求。
根據世界衛生組織(WHO)統計,2019年全球約有 323 萬人死於慢性阻塞性肺病(COPD)。
隨著老年人口的增加,需要氧氣療法的呼吸系統疾病(例如慢性阻塞性肺病(COPD))的盛行率不斷增加。對於需要額外氧氣的人來說,居家照護氧氣濃縮機提供了實用且有效的解決方案,可以在舒適的家中管理他們的醫療狀況。此外,這些人口趨勢日益增加對家庭醫療保健解決方案的需求。
居家照護氧氣濃縮機對消費者來說可能很昂貴,限制了那些買不起的人的使用。阻礙廣泛普及的另一個因素是醫療保險公司的償付問題。家庭長期使用所需的醫療設備成本高昂,導致一些患者無法購買,阻礙了市場成長。因此,為了克服這一障礙並確保擴大居家照護氧氣濃縮機的使用範圍,需要解決負擔能力問題並改善償付政策。
隨著越來越多的老年人更喜歡在自己舒適的家中養老,對方便可靠的家庭氧氣療法解決方案的需求迅速增加。居家照護氧氣濃縮機取代了笨重的氧氣瓶,提供了一種輕巧且方便的替代方案,可以保持患者的自由和活動能力。製造商可以透過開發無噪音、節能且輕巧的設備來受益於技術進步,以滿足對高效家庭呼吸護理不斷成長的需求。全球對醫療保健領域去中心化和經濟高效解決方案的重視推動該市場的擴張。
傳統的居家照護氧氣濃縮機正面臨著穿戴式式和攜帶式供氧技術以及可節省成本和便利的替代技術興起的競爭。醫療保健行業的償付問題和監管變化也可能影響市場擴張。居家照護對氧氣濃縮機的需求可能會受到遠端醫療服務和遠端患者監護的影響。為了降低新市場威脅帶來的風險,該行業的製造商必須保持彈性,以適應不斷發展的技術。
由於病毒引起的呼吸系統併發症激增,對氧氣療法用品(例如用於居家照護的氧氣濃縮機)的需求日益增加。隨著越來越多的人選擇家庭長期氧氣療法治療解決方案,需求不斷成長,市場日益擴大。為了滿足這項需求,製造商迅速提高產量,攜帶式、易於使用的設計創新也越來越受到關注。此外,疫情也推動了遠端醫療服務的普及,透過促進呼吸系統疾病的遠端監測和管理,影響了居家照護氧氣濃縮機市場。
由於其攜帶性和便利性的優勢,攜帶式家庭護理氧氣濃縮機市場居家照護居家照護氧氣濃縮機市場中經歷顯著成長。患有呼吸系統疾病的患者更喜歡攜帶式氧氣濃縮機,因為它們可以讓他們在接受必要的氧氣治療時保持活動狀態。此外,人們對家庭氧氣療法的廣泛了解推動對攜帶式解決方案的需求並擴大市場。
由於效率和攜帶性的提高,居家照護氧氣濃縮機市場的脈衝流區隔經歷顯著成長。脈衝流設備僅在使用者吸氣時輸送氧氣,最大限度地提高氧氣消費量並延長濃縮器的使用壽命。這項功能對於偶爾需要氧氣的患者來說更經濟、節能。脈衝流濃縮器在居家照護氧氣濃縮機領域獲得市場佔有率,這主要是由於家庭醫療保健解決方案的成長趨勢。
由於人口老化、呼吸系統疾病發病率增加以及消費者對家庭醫療保健選擇意識的提高等因素,亞太地區(APAC)居家照護氧氣濃縮機市場快速成長。由於攜帶式氧氣濃縮機的改進和技術創新,市場不斷擴大。此外,持續的 COVID-19 爆發增加了對呼吸護理產品的需求,這推動亞太地區市場的發展。領先的醫療保健提供者和行業參與者之間的合作也有助於推動這些設備的市場動力。
對家庭醫療保健的日益重視、人口老化以及呼吸系統疾病盛行率的上升,促進歐洲居家照護氧氣濃縮機市場的良好成長。 COVID-19 大流行凸顯了呼吸照護的重要性,導致居家照護對氧氣濃縮機的需求增加。支持家庭護理服務的醫療基礎設施和優惠的償付政策也促進了市場的強勁成長。
According to Stratistics MRC, the Global Homecare Oxygen Concentrators Market is accounted for $1.8 billion in 2023 and is expected to reach $3.1 billion by 2030 growing at a CAGR of 8% during the forecast period. The Homecare Oxygen Concentrators market refers to the industry that provides portable and stationary devices designed to deliver concentrated oxygen to individuals with respiratory conditions in the comfort of their homes. Major industry players provide a variety of products with different features and flow rates to meet the needs of different types of patients.
According to the World Health Organization, nearly 3.23 million deaths were caused due to the Chronic Obstructive Pulmonary Disease (COPD), globally, in 2019.
As the elderly population increases, there is a rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and other respiratory conditions that necessitate oxygen therapy. For those in need of extra oxygen, homecare oxygen concentrators provide a practical and efficient solution that enables them to manage their conditions from the comfort of their own homes. Additionally, the demand for home healthcare solutions is increasing due to this demographic trend.
Homecare oxygen concentrators can be expensive for consumers, limiting accessibility for individuals with lower financial means. Further impeding widespread adoption could be reimbursement challenges from health insurance companies. The expense of these necessary medical devices for long-term use at home prevents some patients from affording them, which hinders market growth. Therefore, overcoming this barrier and guaranteeing greater access to homecare oxygen concentrators requires addressing affordability issues and improving reimbursement policies.
As more elderly individuals prefer to age in place, the demand for convenient and reliable home oxygen therapy solutions has surged. In place of bulky oxygen tanks, homecare oxygen concentrators provide a lightweight, convenient substitute that preserves patients' freedom and mobility. Manufacturers can benefit from technological advancements by creating devices that are noise-free, energy-efficient, and lightweight, which will help meet the growing demand for efficient home respiratory care. The growing emphasis on healthcare decentralization and cost-effective solutions worldwide is driving this market's expansion.
Conventional home oxygen concentrators face competition from emerging wearable and portable oxygen delivery technologies, as well as possible cost- and convenience-saving alternatives. The healthcare industry's reimbursement problems and regulatory changes could also affect the market's expansion. The need for homecare oxygen concentrators may be impacted by the move toward telehealth services and remote patient monitoring. To reduce the risk posed by emerging market threats, manufacturers in this industry must remain flexible in their adaptation to evolving technologies.
The need for oxygen therapy supplies, such as home oxygen concentrators, has increased due to the virus's surge in respiratory complications. The market has expanded as a result of the rising demand, with more people choosing home-based solutions for long-term oxygen therapy. To meet this demand, manufacturers have seen a spike in production, and innovations in portable and user-friendly designs are receiving more attention. Furthermore, the pandemic has expedited the uptake of telehealth services, impacting the homecare oxygen concentrator market by encouraging remote respiratory condition monitoring and management.
Because of its benefits of portability and convenience, the portable home oxygen concentrator market within the homecare oxygen concentrator market has experienced significant growth. Patients with respiratory disorders like portable oxygen therapy units because they enable them to continue living an active lifestyle while receiving vital oxygen treatment. In addition, a greater knowledge of the advantages of home oxygen therapy have fueled demand for portable solutions and expanded the market.
The pulse flow segment in the Homecare Oxygen Concentrators market has experienced substantial growth due to its enhanced efficiency and portability. By delivering oxygen only when the user inhales, pulse flow devices maximize oxygen consumption and prolong concentrator life. Because of this feature, they are more economical and energy-efficient for patients with sporadic oxygen needs. Pulse flow concentrators' growing market share in the homecare oxygen concentrators sector is largely due to the growing trend toward at-home healthcare solutions.
The Asia-Pacific (APAC) homecare oxygen concentrator market has grown rapidly due to factors like an aging population, a rise in respiratory disorders, and increased consumer awareness of at-home healthcare options. The market has grown as a result of improvements in portable oxygen concentrators and technological breakthroughs. In addition, the ongoing COVID-19 pandemic has increased the need for respiratory care supplies, which is driving the APAC market. Partnerships between major healthcare providers and industry players have also helped these devices gain traction in the market.
A growing emphasis on home-based healthcare, an aging population, and the rising prevalence of respiratory disorders have all contributed to Europe's Homecare Oxygen Concentrators market's lucrative growth. The need for homecare oxygen concentrators has increased as a result of the COVID-19 pandemic's emphasis on the significance of respiratory care. The healthcare infrastructure that supports homecare services and favorable reimbursement policies have also contributed to the market's strong growth.
Some of the key players in Homecare Oxygen Concentrators market include Air Water Inc, AVIC Jianghang, Beijing North Star, Besco Medical Co., BOC Healthcare (The Linde Group), Chart Industries Inc , Drive DeVibiss Healthcare Inc, Foshan Kaiya, GCE Group, Inogen Inc, Inova Labs Inc. (ResMed), Invacare, Koninklijke Philips N.V., Longfian Scitech Co, NIDEK Medical Products, Inc, O2 Concepts , Philips Respironics, Precision Medical Inc , Teijin and Yuwell (iangsu Yuyue Medical Equipment and Supply Co., Ltd.)
In August 2023, Chart Industries, Inc, a leading global engineering design firm, announced that it has executed a Memorandum of Understanding ("MOU") with 8 Rivers Capital, LLC, to evaluate 8 Rivers' portfolio of proprietary licensable technologies and processes and identify where Chart's technologies and systems can complement or bring added value to the 8 Rivers offerings. This collaboration includes developing equipment for 8 Rivers technologies backed up by Chart's decades of experience in the design and manufacture of cryogenic, compression and process technologies, to assist 8 Rivers in delivering a reliable and cost-effective solution to their customers.
In July 2023, Inogen has signed a definitive agreement for the acquisition of France-based company Physio-Assist in a deal valued at nearly $45m, to bolster its respiratory product portfolio. As per the deal, Physio-Assist is entitled to receive nearly $32m in cash from Inogen at closing, as well as payments on meeting milestones linked to clearance from the Food and Drug Administration for the device.